RAS GTPase Inhibitors

DBCAT005667Pharmacologic class

Drugs that inhibit RAS GTPase. A DrugBank category of 3 drugs. 3 of them are approved.

What you can answer from here — as of November 29, 2022

3DrugsEach linked to its full drug card

Listed above

4Drug targetsEvery drug–target pair in the class, with bond type

19Marketed productsAcross the regions we cover, with dosage forms and routes

1Route of administrationHow the drugs in this class are given

Which targets do RAS GTPase Inhibitors share, and which companies have late-stage candidates in this class?

Create a free account or log in to explore the full data card.